- BNF:
- Not listed
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- March 2015
Comments
DO NOT PRESCRIBE (DNP): NICE TA 332 not recommended for treating asymptomatic or minimally symptomatic metastatic hormone relapsed prostate cancer.
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
search again